Together, these findings opened the door to exploring the therapeutic potential of the SETX–ZPR1 axis in regulating pathogenic R-loops in neurodegenerative diseases subject to abnormal levels of R-loops such as SMA and ALS4. The gene discussed is ZPR1; the disease is neurodegenerative disease.